Aura Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-24.3M | $-25.1M | $771.0K | $736.0K |
| FY2021 | $-32.4M | $-34.5M | $2.1M | $2.3M |
| FY2022 | $-54.6M | $-55.7M | $1.1M | $6.4M |
| FY2023 | $-63.8M | $-64.6M | $709.0K | $8.8M |
| FY2024 | $-79.8M | $-81.1M | $1.3M | $11.7M |
| FY2025 | $-84.7M | $-85.2M | $447.0K | $14.3M |